scholarly journals PHOSPHAN Microplate Technology-Based Microarray For Detection of IgG Antibodies against West Nile, Crimean Congo Hemorrhagic Fever and Tick-Borne Encephalitis Viruses

Author(s):  
V. G. Pomelova ◽  
T. A. Bychenkova ◽  
N. S. Ossin

Demonstrated was the possibility to use PHOSPHAN microplate technology to examine human sera and detect simultaneously specific IgG antibodies to three arboviruses, including the West Nile virus (WNV), Crimean Congo Hemorrhagic Fever virus (CCHFV), and Tick-borne encephalitis virus (TBEV). Both sensitivity and specificity of microarray immunoassay approach were similar to those of ELISA tests (when serum specimens were investigated separately). Using the criterion of 2-fold or stronger reaction of the examined serum specimen with homologous antigen than with heterologous one, we succeeded in differentiation of group specific anti WNV and anti TBEV IgG antibodies in about 60% of cross reactive sera. From the economical standpoint, the PHOSPAN technology may have advantages as compared with currently used ELISAs due to miniaturization of immunoassay format and ability to multiplex.

2011 ◽  
Vol 90 (2) ◽  
pp. A45 ◽  
Author(s):  
Liubov Terekhina ◽  
Nataliya Pripuzova ◽  
Mikhail Vorovitch ◽  
Yulia Rogova ◽  
Lidiya Romanova ◽  
...  

2013 ◽  
Vol 17 (11) ◽  
pp. e1031-e1037 ◽  
Author(s):  
Barry Atkinson ◽  
John Chamberlain ◽  
Lisa J. Jameson ◽  
Christopher H. Logue ◽  
James Lewis ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Sultan Gülce-İz ◽  
Nazif Elaldı ◽  
Hüseyin Can ◽  
Esra Atalay Şahar ◽  
Muhammet Karakavuk ◽  
...  

AbstractCrimean-Congo hemorrhagic fever (CCHF) is a tick-borne viral infection caused by Crimean-Congo hemorrhagic fever virus (CCHFV). Serological screening of CCHF is important and current ELISA use antigens prepared from virus which is expensive due to requirement of high bio-containment facilities. In this study, we aimed to develop a new recombinant ELISA. For this purpose, CCHFV genome were expressed as 13 proteins in E. coli and among them abundantly purified recombinant Nucleocapsid protein (rNP) and Mucin-like variable domain (rMLD) were used as antigen in ELISA (Rec-ELISA). Rec-ELISA using rNP, rMLD and a combination of both (rNP/rMLD) were probed with acute (n = 64; collected between days 1 and 7 after onset of symptoms), convalescent (n = 35; collected 8 days after onset of symptoms), consecutive sera (n = 25) of confirmed CCHF cases and control sera (n = 43). The sensitivity and specificity of Rec-ELISA using rNP/rMLD were 73% and 98% in acute cases and 97% and 98% in convalescent cases. The median interquartile absorbance value to discriminate the acute and convalescent phases of CCHF was significantly higher with ELISA using rNP/rMLD (P < 0.0001) compared to rNP (P > 0.05) and rMLD (P = 0.001). These results indicate that the Rec-ELISA using rNP/rMLD may be very useful to diagnose convalescent CCHF cases especially in field studies.


Sign in / Sign up

Export Citation Format

Share Document